EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Impact of Microbiome on Breast Cancer and Regulatory Strategies

Jiaxin Wang, Dongyan Xu, Shiyao Hu, Beiwen Zheng, Yiding Chen, Tao Pan iD

Microorganisms · 29.12.2025 · 14 (1) · 75

DOI: 10.3390/microorganisms14010075 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 29.12.2025. Verfasst von Jiaxin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer, the most prevalent malignant tumor in women, is closely linked to the human microbiota. The microbiome participates throughout breast cancer pathogenesis, including its occurrence, progression, response to anti-tumor therapies, and treatment-related complications. This review examines the central hypothesis that microbiome-driven inflammatory and immune mechanisms shape breast cancer progression through two key pathways: systemic immune-inflammatory regulation and local tumor microenvironment remodeling. Furthermore, microorganisms and their metabolites modulate systemic treatments by interfering with drug metabolism and altering systemic or local immune-inflammatory environments. Targeting the microbiota represents a promising strategy for enhancing anticancer efficacy and reducing treatment-related complications. This review aims to advance the understanding of the etiology and disease progression of breast cancer from the perspective of microbial-regulated inflammation and immunity, offering new insights for its prevention and treatment.

Schlagwörter

Stichwörter der Autor:innen

breast cancerimmuneinflammationmechanismmicrobiome

Autor:innen und Institutionen

  • Department of Breast Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Medical School, College of Me…
  • Jinan Microecological Biomedicine Shandong Laboratory, Jinan 250022, China.

ORCID-Profile: Tao Pan

Förderung

  • National Natural Science Foundation of China
  • Beijing Medical Foundation

Zitieren

APA

Wang, J., Xu, D., Hu, S., Zheng, B., Chen, Y., & Pan, T. (2025). The Impact of Microbiome on Breast Cancer and Regulatory Strategies. Microorganisms, 14(1), 75. https://doi.org/10.3390/microorganisms14010075

Vancouver

Wang J, Xu D, Hu S, Zheng B, Chen Y, Pan T. The Impact of Microbiome on Breast Cancer and Regulatory Strategies. Microorganisms. 2025;14(1):75. doi:10.3390/microorganisms14010075

BibTeX
@article{Wang2025,
  author = {Wang, Jiaxin and Xu, Dongyan and Hu, Shiyao and Zheng, Beiwen and Chen, Yiding and Pan, Tao},
  title = {The Impact of Microbiome on Breast Cancer and Regulatory Strategies},
  journal = {Microorganisms},
  year = {2025},
  volume = {14},
  number = {1},
  pages = {75},
  doi = {10.3390/microorganisms14010075}
}
Kostenlos starten →